| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10129542 | American Heart Journal | 2018 | 31 Pages |
Abstract
HAPR was infrequently present in a large registry of patients undergoing PCI. There was no clear relationship between HAPR and 2-year clinical outcomes. Investigations of antiplatelet regimens without aspirin after DES implantation are ongoing and should inform future management of patients undergoing PCI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christine J. MD, Ajay J. MD, SM, Yiran MS, Bernhard MD, Giora MD, Thomas D. MD, Bruce R. MD, Michael J. MD, Franz-Josef MD, D. Christopher MD, Timothy D. MD, David A. MD, Peter L. MD, MMM, Ernest L. MD, Roxana MD, Gregg W. MD,